The VICTUS laser platform has CE Mark for lens fragmentation, capsulotomy, creation of flaps, INTRACOR and arcuate corneal incisions.
The VICTUS femtosecond laser platform received FDA clearance in July 2012.
More Articles on Ophthalmology:
NovaBay Pharmaceuticals Begins Patient Trial of Pink-Eye Treatment
FDA Approves PROLENSA from Bausch + Lomb
Arizona Aiello Eye Institute Expands Services at Foothills Location
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
